Reta 10 mg lyophilised vial
Shipping worldwideTracked, dispatched from inside the EU
Dispatched same working dayOn orders paid before 2:00 PM
Customs & importRules vary by country — check yours before ordering
Real supportWhatsApp & email

Reta 10 mg

Lyophilised research material

from €88.95 per unit
Choose variant

Also in 20 mg — €168.95

Reta 1 × €88.95
€88.95
Peptide offer
Shipping tracked
€9.95
Total
€98.90
Product details

Reta 10mg

Reta 10 mg lyophilised powder in a sealed vial for in-vitro laboratory research.

All presented information is based on scientific publications which can be found at the end of product description below.

Janoshik 222314

  1. 1Usage of peptide

    The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, ect.

  2. 2Peptides in transport

    Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.

  3. 3Storage of lyophilized peptides

    Upon receiving the lyophilized peptide, store at 4 °C or colder and away from bright light. Lyophilized peptides are stable at room temperature for weeks, but for longer-term storage, it is safer to store at -20 °C or colder. Exposure to moisture will greatly decrease long-term stability of lyophilized peptides. Before using the peptide, remove from cold storage and allow the peptide to equilibrate to room temperature before removing the lid of the container, in order to reduce the uptake of moisture that is present in the surrounding atmosphere.

  4. 4Storage of peptide solutions

    The shelf life of peptide solutions is limited. Freezing the aliquots will prolong the storage life of the peptide. What is globally accepted for peptides in solution is that they are generally stable for 3 or more weeks at +4°C and for 3-4 months at -20°C. Avoid repeated freeze-thaw cycles, as this can degrade the peptides.

Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use

Reta 10 mg questions

Which Reta vial size is this?

This page is for the 10 mg lyophilised Reta research vial. The 20 mg vial is a separate listing. These figures identify the listed mass, not a prepared solution concentration.

Which independent report is available for Reta?

Janoshik report 222314 is published for Reta. The tested sample was labelled 10 mg. The result describes the sample tested; it does not establish the contents of every vial. The laboratory verification page provides the original result.

Does this listing supply a ready-to-use medicine?

No. This is a laboratory research material listing. The product is supplied lyophilised, not as a prefilled device or finished medicine. See the research-use policy.

Where can I check delivery and payment details?

See shipping and returns for delivery information. Available payment options are shown at checkout. For a destination or order question, contact us before ordering.

Related reading
Research & references

Description of Reta

Reta is an investigational synthetic peptide studied for activity at the GLP-1, GIP and glucagon receptors.

Overview of Published Research

The references below are background literature on Reta, including laboratory and clinical investigations. They do not describe testing of this product. Consult each publication for its study material, methods and limitations.

References

  1. „Reta (LY3437943): A Novel Tri-agonist Peptide for Metabolic Disease Treatment“, 2025.
  2. Alaa Abdrabou Abouelmagd et al., „Efficacy and safety of Reta, a novel GLP-1, GIP, and GCG receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials“, 2025.
  3. Coskun T, Urva S, Roell WC, et al. LY3437943, a novel triple GCG, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metab. 2022;34(9):1234–1247.e9. doi: 10.1016/j.cmet.2022.07.013
  4. Sanyal AJ, Kaplan LM, Frias JP, et al. Triple hormone receptor agonist Reta for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nat Med. 2024;30(7):2037–2048. doi: 10.1038/s41591-024-03018-2
  5. Jastreboff AM, Kaplan LM, Frías JP, et al. Triple–hormone-receptor agonist Reta for obesity—a phase 2 trial. N Engl J Med. 2023;389(6):514–526. doi: 10.1056/NEJMoa2301972
  6. Rosenstock J, Frias J, Jastreboff AM, et al. Reta, a GIP, GLP-1 and GCG receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. Lancet. 2023;402(10401):529–544. doi: 10.1016/S0140-6736(23)01053-X
  7. Urva S, Coskun T, Loh MT, et al. LY3437943, a novel triple GIP, GLP-1, and GCG receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial. Lancet. 2022;400(10366):1869–1881. doi: 10.1016/S0140-6736(22)02033-5
Also in stock

Also in stock

All products →
Glow Blend research vial
In stock

Glow Blend

€101.95

GHK-Cu research vial
In stock

GHK-Cu

€34.95

C14H22CuN6O4
Glutathione research vial
Out of stock

Glutathione

€58.95

C10H17N3O6S
Melanotan 2 research vial
In stock

Melanotan 2

€49.95

C50H69N15O9
NAD+ research vial
In stock

NAD+

€63.95

C21H27N7O14P2
Selank research vial
In stock

Selank

€29.95

C33H57N11O9